 | • レポートコード：D0GIR-02525 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、遺伝子組み換えサブユニットワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。遺伝子組み換えサブユニットワクチンの種類別市場規模（治療用遺伝子組換えサブユニットワクチン、予防用遺伝子組換えサブユニットワクチン）、用途別市場規模（人間用、獣医用）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Merck、Sanofi Pasteur SA、Pulike、GSK、Yebio、Tiantan、Pfizer Inc.、CureVac、Greffex、Virbac、Walvax Biotechnology、Kontec ・地域別グローバル市場分析 2015年-2020年 ・遺伝子組み換えサブユニットワクチンの北米市場（アメリカ、カナダ、メキシコ） ・遺伝子組み換えサブユニットワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・遺伝子組み換えサブユニットワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・遺伝子組み換えサブユニットワクチンの南米市場（ブラジル、アルゼンチン） ・遺伝子組み換えサブユニットワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：治療用遺伝子組換えサブユニットワクチン、予防用遺伝子組換えサブユニットワクチン ・用途別分析：人間用、獣医用 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Gene Engineered Subunit Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Gene Engineered Subunit Vaccine sales will be xx in 2020 from Gene Engineered Subunit Vaccine million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Gene Engineered Subunit Vaccine market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Gene Engineered Subunit Vaccine industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Gene Engineered Subunit Vaccine and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Gene Engineered Subunit Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Gene Engineered Subunit Vaccine market has been segmented into:
Therapeutic Gene Engineered Subunit Vaccine
Preventative Gene Engineered Subunit Vaccine
By Application, Gene Engineered Subunit Vaccine has been segmented into:
Human Use
Veterinary Use
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gene Engineered Subunit Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Gene Engineered Subunit Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gene Engineered Subunit Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Gene Engineered Subunit Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Gene Engineered Subunit Vaccine Market Share Analysis
Gene Engineered Subunit Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gene Engineered Subunit Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gene Engineered Subunit Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Gene Engineered Subunit Vaccine are:
Merck
Sanofi Pasteur SA
Pulike
GSK
Yebio
Tiantan
Pfizer Inc.
CureVac
Greffex
Virbac
Walvax Biotechnology
Kontec
Among other players domestic and global, Gene Engineered Subunit Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Gene Engineered Subunit Vaccine Market Overview
1.1 Product Overview and Scope of Gene Engineered Subunit Vaccine
1.2 Classification of Gene Engineered Subunit Vaccine by Type
1.2.1 Global Gene Engineered Subunit Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Gene Engineered Subunit Vaccine Revenue Market Share by Type in 2019
1.2.3 Therapeutic Gene Engineered Subunit Vaccine
1.2.4 Preventative Gene Engineered Subunit Vaccine
1.3 Global Gene Engineered Subunit Vaccine Market by Application
1.3.1 Overview: Global Gene Engineered Subunit Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Human Use
1.3.3 Veterinary Use
1.4 Global Gene Engineered Subunit Vaccine Market by Regions
1.4.1 Global Gene Engineered Subunit Vaccine Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Gene Engineered Subunit Vaccine (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Gene Engineered Subunit Vaccine Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Gene Engineered Subunit Vaccine Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gene Engineered Subunit Vaccine Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Gene Engineered Subunit Vaccine Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gene Engineered Subunit Vaccine Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Gene Engineered Subunit Vaccine Industry Impact
1.5.1 COVID-19 Potential Implications for the Gene Engineered Subunit Vaccine
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Gene Engineered Subunit Vaccine
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi Pasteur SA
2.2.1 Sanofi Pasteur SA Details
2.2.2 Sanofi Pasteur SA Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi Pasteur SA SWOT Analysis
2.2.4 Sanofi Pasteur SA Product and Services
2.2.5 Sanofi Pasteur SA Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pulike
2.3.1 Pulike Details
2.3.2 Pulike Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pulike SWOT Analysis
2.3.4 Pulike Product and Services
2.3.5 Pulike Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.4 GSK
2.4.1 GSK Details
2.4.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GSK SWOT Analysis
2.4.4 GSK Product and Services
2.4.5 GSK Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.5 Yebio
2.5.1 Yebio Details
2.5.2 Yebio Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Yebio SWOT Analysis
2.5.4 Yebio Product and Services
2.5.5 Yebio Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.6 Tiantan
2.6.1 Tiantan Details
2.6.2 Tiantan Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Tiantan SWOT Analysis
2.6.4 Tiantan Product and Services
2.6.5 Tiantan Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pfizer Inc.
2.7.1 Pfizer Inc. Details
2.7.2 Pfizer Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Pfizer Inc. SWOT Analysis
2.7.4 Pfizer Inc. Product and Services
2.7.5 Pfizer Inc. Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.8 CureVac
2.8.1 CureVac Details
2.8.2 CureVac Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 CureVac SWOT Analysis
2.8.4 CureVac Product and Services
2.8.5 CureVac Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.9 Greffex
2.9.1 Greffex Details
2.9.2 Greffex Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Greffex SWOT Analysis
2.9.4 Greffex Product and Services
2.9.5 Greffex Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.10 Virbac
2.10.1 Virbac Details
2.10.2 Virbac Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Virbac SWOT Analysis
2.10.4 Virbac Product and Services
2.10.5 Virbac Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.11 Walvax Biotechnology
2.11.1 Walvax Biotechnology Details
2.11.2 Walvax Biotechnology Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Walvax Biotechnology SWOT Analysis
2.11.4 Walvax Biotechnology Product and Services
2.11.5 Walvax Biotechnology Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.12 Kontec
2.12.1 Kontec Details
2.12.2 Kontec Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Kontec SWOT Analysis
2.12.4 Kontec Product and Services
2.12.5 Kontec Gene Engineered Subunit Vaccine Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Gene Engineered Subunit Vaccine Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Gene Engineered Subunit Vaccine Players Market Share
3.2.2 Top 10 Gene Engineered Subunit Vaccine Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Gene Engineered Subunit Vaccine Revenue and Market Share by Regions
4.2 North America Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
4.3 Europe Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
4.5 South America Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
5 North America Gene Engineered Subunit Vaccine Revenue by Countries
5.1 North America Gene Engineered Subunit Vaccine Revenue by Countries (2015-2020)
5.2 USA Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
5.3 Canada Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
5.4 Mexico Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
6 Europe Gene Engineered Subunit Vaccine Revenue by Countries
6.1 Europe Gene Engineered Subunit Vaccine Revenue by Countries (2015-2020)
6.2 Germany Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
6.3 UK Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
6.4 France Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
6.5 Russia Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
6.6 Italy Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Gene Engineered Subunit Vaccine Revenue by Countries
7.1 Asia-Pacific Gene Engineered Subunit Vaccine Revenue by Countries (2015-2020)
7.2 China Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
7.3 Japan Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
7.4 Korea Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
7.5 India Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
8 South America Gene Engineered Subunit Vaccine Revenue by Countries
8.1 South America Gene Engineered Subunit Vaccine Revenue by Countries (2015-2020)
8.2 Brazil Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
8.3 Argentina Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Gene Engineered Subunit Vaccine by Countries
9.1 Middle East & Africa Gene Engineered Subunit Vaccine Revenue by Countries (2015-2020)
9.2 Saudi Arabia Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
9.3 UAE Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
9.4 Egypt Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
9.5 South Africa Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Gene Engineered Subunit Vaccine Revenue and Market Share by Type (2015-2020)
10.2 Global Gene Engineered Subunit Vaccine Market Forecast by Type (2019-2024)
10.3 Therapeutic Gene Engineered Subunit Vaccine Revenue Growth Rate (2015-2025)
10.4 Preventative Gene Engineered Subunit Vaccine Revenue Growth Rate (2015-2025)
11 Global Gene Engineered Subunit Vaccine Market Segment by Application
11.1 Global Gene Engineered Subunit Vaccine Revenue Market Share by Application (2015-2020)
11.2 Gene Engineered Subunit Vaccine Market Forecast by Application (2019-2024)
11.3 Human Use Revenue Growth (2015-2020)
11.4 Veterinary Use Revenue Growth (2015-2020)
12 Global Gene Engineered Subunit Vaccine Market Size Forecast (2021-2025)
12.1 Global Gene Engineered Subunit Vaccine Market Size Forecast (2021-2025)
12.2 Global Gene Engineered Subunit Vaccine Market Forecast by Regions (2021-2025)
12.3 North America Gene Engineered Subunit Vaccine Revenue Market Forecast (2021-2025)
12.4 Europe Gene Engineered Subunit Vaccine Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Gene Engineered Subunit Vaccine Revenue Market Forecast (2021-2025)
12.6 South America Gene Engineered Subunit Vaccine Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Gene Engineered Subunit Vaccine Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Gene Engineered Subunit Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Gene Engineered Subunit Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gene Engineered Subunit Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Gene Engineered Subunit Vaccine Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Gene Engineered Subunit Vaccine Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Merck Corporate Information, Location and Competitors
Table 7. Merck Gene Engineered Subunit Vaccine Major Business
Table 8. Merck Gene Engineered Subunit Vaccine Total Revenue (USD Million) (2017-2018)
Table 9. Merck SWOT Analysis
Table 10. Merck Gene Engineered Subunit Vaccine Product and Solutions
Table 11. Merck Gene Engineered Subunit Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Sanofi Pasteur SA Corporate Information, Location and Competitors
Table 13. Sanofi Pasteur SA Gene Engineered Subunit Vaccine Major Business
Table 14. Sanofi Pasteur SA Gene Engineered Subunit Vaccine Total Revenue (USD Million) (2018-2019)
Table 15. Sanofi Pasteur SA SWOT Analysis
Table 16. Sanofi Pasteur SA Gene Engineered Subunit Vaccine Product and Solutions
Table 17. Sanofi Pasteur SA Gene Engineered Subunit Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Pulike Corporate Information, Location and Competitors
Table 19. Pulike Gene Engineered Subunit Vaccine Major Business
Table 20. Pulike Gene Engineered Subunit Vaccine Total Revenue (USD Million) (2017-2018)
Table 21. Pulike SWOT Analysis
Table 22. Pulike Gene Engineered Subunit Vaccine Product and Solutions
Table 23. Pulike Gene Engineered Subunit Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. GSK Corporate Information, Location and Competitors
Table 25. GSK Gene Engineered Subunit Vaccine Major Business
Table 26. GSK Gene Engineered Subunit Vaccine Total Revenue (USD Million) (2017-2018)
Table 27. GSK SWOT Analysis
Table 28. GSK Gene Engineered Subunit Vaccine Product and Solutions
Table 29. GSK Gene Engineered Subunit Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Yebio Corporate Information, Location and Competitors
Table 31. Yebio Gene Engineered Subunit Vaccine Major Business
Table 32. Yebio Gene Engineered Subunit Vaccine Total Revenue (USD Million) (2017-2018)
Table 33. Yebio SWOT Analysis
Table 34. Yebio Gene Engineered Subunit Vaccine Product and Solutions
Table 35. Yebio Gene Engineered Subunit Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Tiantan Corporate Information, Location and Competitors
Table 37. Tiantan Gene Engineered Subunit Vaccine Major Business
Table 38. Tiantan Gene Engineered Subunit Vaccine Total Revenue (USD Million) (2017-2018)
Table 39. Tiantan SWOT Analysis
Table 40. Tiantan Gene Engineered Subunit Vaccine Product and Solutions
Table 41. Tiantan Gene Engineered Subunit Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Pfizer Inc. Corporate Information, Location and Competitors
Table 43. Pfizer Inc. Gene Engineered Subunit Vaccine Major Business
Table 44. Pfizer Inc. Gene Engineered Subunit Vaccine Total Revenue (USD Million) (2017-2018)
Table 45. Pfizer Inc. SWOT Analysis
Table 46. Pfizer Inc. Gene Engineered Subunit Vaccine Product and Solutions
Table 47. Pfizer Inc. Gene Engineered Subunit Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. CureVac Corporate Information, Location and Competitors
Table 49. CureVac Gene Engineered Subunit Vaccine Major Business
Table 50. CureVac Gene Engineered Subunit Vaccine Total Revenue (USD Million) (2017-2018)
Table 51. CureVac SWOT Analysis
Table 52. CureVac Gene Engineered Subunit Vaccine Product and Solutions
Table 53. CureVac Gene Engineered Subunit Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Greffex Corporate Information, Location and Competitors
Table 55. Greffex Gene Engineered Subunit Vaccine Major Business
Table 56. Greffex Gene Engineered Subunit Vaccine Total Revenue (USD Million) (2017-2018)
Table 57. Greffex SWOT Analysis
Table 58. Greffex Gene Engineered Subunit Vaccine Product and Solutions
Table 59. Greffex Gene Engineered Subunit Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Virbac Corporate Information, Location and Competitors
Table 61. Virbac Gene Engineered Subunit Vaccine Major Business
Table 62. Virbac Gene Engineered Subunit Vaccine Total Revenue (USD Million) (2017-2018)
Table 63. Virbac SWOT Analysis
Table 64. Virbac Gene Engineered Subunit Vaccine Product and Solutions
Table 65. Virbac Gene Engineered Subunit Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Walvax Biotechnology Corporate Information, Location and Competitors
Table 67. Walvax Biotechnology Gene Engineered Subunit Vaccine Major Business
Table 68. Walvax Biotechnology Gene Engineered Subunit Vaccine Total Revenue (USD Million) (2017-2018)
Table 69. Walvax Biotechnology SWOT Analysis
Table 70. Walvax Biotechnology Gene Engineered Subunit Vaccine Product and Solutions
Table 71. Walvax Biotechnology Gene Engineered Subunit Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Kontec Corporate Information, Location and Competitors
Table 73. Kontec Gene Engineered Subunit Vaccine Major Business
Table 74. Kontec Gene Engineered Subunit Vaccine Total Revenue (USD Million) (2017-2018)
Table 75. Kontec SWOT Analysis
Table 76. Kontec Gene Engineered Subunit Vaccine Product and Solutions
Table 77. Kontec Gene Engineered Subunit Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Global Gene Engineered Subunit Vaccine Revenue (Million USD) by Players (2015-2020)
Table 79. Global Gene Engineered Subunit Vaccine Revenue Share by Players (2015-2020)
Table 80. Global Gene Engineered Subunit Vaccine Revenue (Million USD) by Regions (2015-2020)
Table 81. Global Gene Engineered Subunit Vaccine Revenue Market Share by Regions (2015-2020)
Table 82. North America Gene Engineered Subunit Vaccine Revenue by Countries (2015-2020)
Table 83. North America Gene Engineered Subunit Vaccine Revenue Market Share by Countries (2015-2020)
Table 84. Europe Gene Engineered Subunit Vaccine Revenue (Million USD) by Countries (2015-2020)
Table 85. Asia-Pacific Gene Engineered Subunit Vaccine Revenue (Million USD) by Countries (2015-2020)
Table 86. South America Gene Engineered Subunit Vaccine Revenue by Countries (2015-2020)
Table 87. South America Gene Engineered Subunit Vaccine Revenue Market Share by Countries (2015-2020)
Table 88. Middle East and Africa Gene Engineered Subunit Vaccine Revenue (Million USD) by Countries (2015-2020)
Table 89. Middle East and Africa Gene Engineered Subunit Vaccine Revenue Market Share by Countries (2015-2020)
Table 90. Global Gene Engineered Subunit Vaccine Revenue (Million USD) by Type (2015-2020)
Table 91. Global Gene Engineered Subunit Vaccine Revenue Share by Type (2015-2020)
Table 92. Global Gene Engineered Subunit Vaccine Revenue Forecast by Type (2021-2025)
Table 93. Global Gene Engineered Subunit Vaccine Revenue by Application (2015-2020)
Table 94. Global Gene Engineered Subunit Vaccine Revenue Share by Application (2015-2020)
Table 95. Global Gene Engineered Subunit Vaccine Revenue Forecast by Application (2021-2025)
Table 96. Global Gene Engineered Subunit Vaccine Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Gene Engineered Subunit Vaccine Picture
Figure 2. Global Gene Engineered Subunit Vaccine Revenue Market Share by Type in 2019
Figure 3. Therapeutic Gene Engineered Subunit Vaccine Picture
Figure 4. Preventative Gene Engineered Subunit Vaccine Picture
Figure 5. Gene Engineered Subunit Vaccine Revenue Market Share by Application in 2019
Figure 6. Human Use Picture
Figure 7. Veterinary Use Picture
Figure 8. Global Gene Engineered Subunit Vaccine Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Gene Engineered Subunit Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Gene Engineered Subunit Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Gene Engineered Subunit Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Gene Engineered Subunit Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Gene Engineered Subunit Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Gene Engineered Subunit Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Gene Engineered Subunit Vaccine Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Gene Engineered Subunit Vaccine Revenue Market Share in 2019
Figure 17. Global Top 10 Players Gene Engineered Subunit Vaccine Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Gene Engineered Subunit Vaccine Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Gene Engineered Subunit Vaccine Revenue Market Share by Regions (2015-2020)
Figure 21. Global Gene Engineered Subunit Vaccine Revenue Market Share by Regions in 2018
Figure 22. North America Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 23. Europe Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 25. South America Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 27. North America Gene Engineered Subunit Vaccine Revenue Market Share by Countries (2015-2020)
Figure 28. North America Gene Engineered Subunit Vaccine Revenue Market Share by Countries in 2019
Figure 29. USA Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 30. Canada Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 32. Europe Gene Engineered Subunit Vaccine Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Gene Engineered Subunit Vaccine Revenue Market Share by Countries in 2019
Figure 34. Germany Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 35. UK Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 36. France Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 37. Russia Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 38. Italy Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Gene Engineered Subunit Vaccine Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Gene Engineered Subunit Vaccine Revenue Market Share by Countries in 2019
Figure 41. China Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 42. Japan Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 43. Korea Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 44. India Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 46. South America Gene Engineered Subunit Vaccine Revenue Market Share by Countries (2015-2020)
Figure 47. South America Gene Engineered Subunit Vaccine Revenue Market Share by Countries in 2019
Figure 48. Brazil Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Gene Engineered Subunit Vaccine Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Gene Engineered Subunit Vaccine Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 53. UAE Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Gene Engineered Subunit Vaccine Revenue and Growth Rate (2015-2020)
Figure 56. Global Gene Engineered Subunit Vaccine Revenue Share by Type (2015-2020)
Figure 57. Global Gene Engineered Subunit Vaccine Revenue Share by Type in 2019
Figure 58. Global Gene Engineered Subunit Vaccine Market Share Forecast by Type (2021-2025)
Figure 59. Global Therapeutic Gene Engineered Subunit Vaccine Revenue Growth Rate (2015-2020)
Figure 60. Global Preventative Gene Engineered Subunit Vaccine Revenue Growth Rate (2015-2020)
Figure 61. Global Gene Engineered Subunit Vaccine Revenue Share by Application (2015-2020)
Figure 62. Global Gene Engineered Subunit Vaccine Revenue Share by Application in 2019
Figure 63. Global Gene Engineered Subunit Vaccine Market Share Forecast by Application (2021-2025)
Figure 64. Global Human Use Revenue Growth Rate (2015-2020)
Figure 65. Global Veterinary Use Revenue Growth Rate (2015-2020)
Figure 66. Global Gene Engineered Subunit Vaccine Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Gene Engineered Subunit Vaccine Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Gene Engineered Subunit Vaccine Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Gene Engineered Subunit Vaccine Revenue Market Forecast (2021-2025)
Figure 70. Europe Gene Engineered Subunit Vaccine Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Gene Engineered Subunit Vaccine Revenue Market Forecast (2021-2025)
Figure 72. South America Gene Engineered Subunit Vaccine Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Gene Engineered Subunit Vaccine Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
インフルエンザ（インフルエンザ）ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Flu (Influenza) Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…- 出血熱ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Hemorrhagic Fever Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- ヒトロタウイルスワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Human Rotavirus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.0% in the forecast period of 2020 to 2025 and will expected to reach USD 8763 million by 2025, from USD 6949.3 million in 2019. The Human Rotaviru…
- エボラワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Ebola Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- エンジニアードクォーツ（E-Quartz）カウンタートップの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Engineered Quartz (E-Quartz) Countertops market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value …